AZELASTINE HCL

AZELASTINE HCL was reported 1427 times

AZELASTINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY VAGINA ABNORMAL 1 0.2000
1 CNS GERMINOMA 1 0.0625
2 BREAST ANGIOSARCOMA 1 0.0400
3 ANDROGENS ABNORMAL 1 0.0227
4 ANALGESIC DRUG LEVEL DECREASED 1 0.0227
5 INCISION SITE ULCER 1 0.0208
6 DRUG DEPENDENCE, ANTEPARTUM 1 0.0192
7 ACTINIC ELASTOSIS 1 0.0132
8 GASTROINTESTINAL AMYLOIDOSIS 1 0.0120
9 CORNEAL BLEEDING 1 0.0104
10 ATRIOVENTRICULAR BLOCK THIRD DEGREE 1 0.0104
11 ALLERGIC BRONCHITIS 1 0.0090
12 HYPNOPOMPIC HALLUCINATION 1 0.0081
13 OESOPHAGEAL INJURY 3 0.0078
14 GALLBLADDER OBSTRUCTION 2 0.0075
15 DRUG REHABILITATION 1 0.0071
16 AMINO ACID LEVEL DECREASED 2 0.0059
17 ABSCESS FUNGAL 1 0.0057
18 COR PULMONALE CHRONIC 1 0.0053
19 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
20 CHRONIC PIGMENTED PURPURA 1 0.0051
21 HERNIA HIATUS REPAIR 1 0.0049
22 NASAL DISCOMFORT 33 0.0042
23 DENTURE WEARER 1 0.0039
24 EAR TUBE INSERTION 1 0.0034
25 PLASMA CELL LEUKAEMIA 2 0.0033
26 BRONCHOSPASM PARADOXICAL 1 0.0033
27 DECREASED EYE CONTACT 1 0.0033
28 COMPULSIVE HOARDING 1 0.0031
29 INJECTION SITE ANAESTHESIA 1 0.0031
30 ADMINISTRATION SITE SWELLING 1 0.0031
31 DYSTHYMIC DISORDER 1 0.0030
32 DECREASED VIBRATORY SENSE 1 0.0029
33 ACQUIRED OESOPHAGEAL WEB 1 0.0029
34 DIAPHRAGMALGIA 1 0.0029
35 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
36 CYSTITIS ESCHERICHIA 1 0.0028
37 EXANTHEM 1 0.0028
38 METAPNEUMOVIRUS INFECTION 2 0.0026
39 FACTOR V LEIDEN MUTATION 1 0.0025
40 CANDIDA TEST POSITIVE 1 0.0024
41 GLIOSIS 1 0.0023
42 HAEMORRHOID OPERATION 1 0.0022
43 EHLERS-DANLOS SYNDROME 1 0.0022
44 PRODUCT EXPIRATION DATE ISSUE 3 0.0021
45 INTERVERTEBRAL DISC INJURY 1 0.0021
46 PRODUCT AFTER TASTE 2 0.0021
47 NASAL INFLAMMATION 2 0.0019
48 NASAL ULCER 3 0.0019
49 UTERINE PROLAPSE 2 0.0018
50 PNEUMONIA STREPTOCOCCAL 2 0.0018
51 NAIL GROWTH ABNORMAL 2 0.0018
52 PHARYNGEAL INFLAMMATION 2 0.0016
53 HELICOBACTER GASTRITIS 2 0.0016
54 NASAL PRURITUS 2 0.0016
55 GASTROINTESTINAL EROSION 1 0.0016
56 OESOPHAGEAL ULCER 6 0.0016
57 BLADDER IRRITATION 1 0.0016
58 ANISOCYTOSIS 1 0.0015
59 GINGIVAL DISCOMFORT 1 0.0015
60 INFUSION SITE URTICARIA 1 0.0015
61 BONE DEFORMITY 1 0.0015
62 RHINALGIA 4 0.0015
63 CEREBRAL CYST 1 0.0015
64 NASAL DRYNESS 9 0.0014
65 DERMATITIS DIAPER 1 0.0014
66 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
67 PRECANCEROUS CELLS PRESENT 2 0.0014
68 CONNECTIVE TISSUE DISORDER 2 0.0014
69 DYSHIDROTIC ECZEMA 1 0.0014
70 DENTAL RESTORATION FAILURE 1 0.0014
71 DYSLALIA 1 0.0014
72 ACCOMMODATION DISORDER 1 0.0014
73 PULMONARY FUNCTION TEST DECREASED 6 0.0014
74 PRODUCT LOT NUMBER ISSUE 3 0.0014
75 AMINO ACID LEVEL INCREASED 1 0.0013
76 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
77 HYPOSMIA 2 0.0013
78 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
79 POLYCYSTIC OVARIES 2 0.0013
80 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
81 INFECTION PARASITIC 1 0.0013
82 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
83 EYELID EXFOLIATION 1 0.0013
84 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
85 CHEMICAL INJURY 1 0.0012
86 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
87 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
88 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
89 GASTROENTERITIS SALMONELLA 1 0.0012
90 EDUCATIONAL PROBLEM 2 0.0012
91 ALLERGIC SINUSITIS 1 0.0012
92 ADENOMA BENIGN 1 0.0012
93 ACUTE SINUSITIS 2 0.0012
94 CEREBELLAR ATROPHY 1 0.0011
95 WHITE BLOOD CELL DISORDER 3 0.0011
96 INJECTION SITE DRYNESS 1 0.0011
97 MIGRAINE WITH AURA 3 0.0011
98 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
99 HYPOGLYCAEMIC SEIZURE 1 0.0011
100 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
101 HAEMOCHROMATOSIS 1 0.0011
102 ACTINOMYCOSIS 1 0.0010
103 OESOPHAGEAL DISORDER 4 0.0010
104 ANIMAL SCRATCH 1 0.0010
105 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
106 MULTIPLE ALLERGIES 8 0.0010
107 HYPOGEUSIA 2 0.0010
108 JOINT NOISE 2 0.0010
109 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
110 BLEPHARITIS 4 0.0010
111 BRAIN HYPOXIA 1 0.0010
112 DROWNING 1 0.0010
113 CARPAL TUNNEL DECOMPRESSION 1 0.0009
114 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
115 HYPERTENSIVE NEPHROPATHY 1 0.0009
116 SNEEZING 21 0.0009
117 INFUSION SITE MASS 1 0.0009
118 INSTILLATION SITE REACTION 1 0.0009
119 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
120 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
121 SINUS DISORDER 18 0.0009
122 MIDDLE EAR EFFUSION 2 0.0009
123 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
124 FACIAL SPASM 1 0.0009
125 ADMINISTRATION SITE PAIN 1 0.0009
126 ACUTE PRERENAL FAILURE 1 0.0009
127 INCISION SITE PAIN 1 0.0009
128 DEVICE DISPENSING ERROR 1 0.0008
129 INSTILLATION SITE IRRITATION 1 0.0008
130 EOSINOPHIL COUNT INCREASED 7 0.0008
131 LACUNAR INFARCTION 2 0.0008
132 BLADDER PROLAPSE 1 0.0008
133 DENTAL OPERATION 2 0.0008
134 EYELID IRRITATION 2 0.0008
135 URINARY TRACT INFECTION BACTERIAL 2 0.0008
136 FRACTURED COCCYX 1 0.0008
137 PARANASAL SINUS HYPERSECRETION 3 0.0008
138 BRONCHIAL SECRETION RETENTION 1 0.0008
139 SEASONAL ALLERGY 11 0.0008
140 GASTROENTERITIS NOROVIRUS 1 0.0008
141 HIRSUTISM 1 0.0008
142 NASAL DISORDER 2 0.0008
143 BODY MASS INDEX INCREASED 1 0.0007
144 ERYTHEMA OF EYELID 4 0.0007
145 LIP BLISTER 2 0.0007
146 CORNEAL OPACITY 1 0.0007
147 SUBDURAL HAEMORRHAGE 2 0.0007
148 DISCHARGE 1 0.0007
149 CHRONIC FATIGUE SYNDROME 1 0.0007
150 BRONCHIAL OBSTRUCTION 1 0.0007
151 PRODUCT USE COMPLAINT 11 0.0007
152 CONJUNCTIVITIS ALLERGIC 1 0.0007
153 FEELING DRUNK 5 0.0007
154 CALCULUS URINARY 1 0.0006
155 GASTROSTOMY 1 0.0006
156 FAMILY STRESS 2 0.0006
157 PRE-EXISTING CONDITION IMPROVED 4 0.0006
158 INTRA-UTERINE DEATH 1 0.0006
159 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
160 VULVOVAGINAL DRYNESS 2 0.0006
161 COLONIC POLYP 1 0.0006
162 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
163 ENTERITIS INFECTIOUS 1 0.0006
164 INCREASED UPPER AIRWAY SECRETION 3 0.0006
165 REGURGITATION 2 0.0006
166 CHOREA 1 0.0006
167 PAPULE 4 0.0006
168 LUNG TRANSPLANT 2 0.0006
169 INDURATION 1 0.0006
170 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
171 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
172 HYPERSEXUALITY 1 0.0005
173 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
174 SNORING 2 0.0005
175 PARANASAL SINUS DISCOMFORT 2 0.0005
176 BLOOD COUNT ABNORMAL 8 0.0005
177 RENAL FAILURE CHRONIC 4 0.0005
178 HYPERAEMIA 1 0.0005
179 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
180 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
181 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
182 SINUS HEADACHE 3 0.0005
183 EMPYEMA 1 0.0005
184 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
185 CANDIDIASIS 2 0.0005
186 VITAMIN B12 DEFICIENCY 2 0.0005
187 EYELID PAIN 1 0.0005
188 TRIGGER FINGER 2 0.0005
189 COMPULSIVE SHOPPING 1 0.0005
190 THYROID FUNCTION TEST ABNORMAL 2 0.0005
191 BODY TEMPERATURE FLUCTUATION 1 0.0005
192 EAR SWELLING 1 0.0005
193 HEPATIC NEOPLASM MALIGNANT 1 0.0005
194 TONGUE DISCOMFORT 2 0.0005
195 BODY HEIGHT DECREASED 5 0.0005
196 INFUSION SITE BRUISING 1 0.0005
197 SOMNAMBULISM 3 0.0005
198 CORNEAL DISORDER 1 0.0005
199 VULVOVAGINAL DISCOMFORT 2 0.0005
200 GASTROINTESTINAL ULCER 1 0.0005
201 RHINITIS ALLERGIC 2 0.0004
202 BACTERIAL TEST POSITIVE 1 0.0004
203 POST-TRAUMATIC STRESS DISORDER 3 0.0004
204 BRONCHIECTASIS 3 0.0004
205 ANAL INCONTINENCE 4 0.0004
206 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
207 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
208 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
209 CROHN'S DISEASE 3 0.0004
210 EAR DISORDER 2 0.0004
211 INCREASED TENDENCY TO BRUISE 4 0.0004
212 NEPHROGENIC ANAEMIA 2 0.0004
213 AUTOIMMUNE HEPATITIS 3 0.0004
214 FEELING OF DESPAIR 2 0.0004
215 FAECAL INCONTINENCE 2 0.0004
216 PANIC REACTION 3 0.0004
217 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
218 NASAL POLYPS 2 0.0004
219 BREATH SOUNDS ABNORMAL 2 0.0004
220 CARTILAGE INJURY 1 0.0004
221 INSTILLATION SITE PAIN 1 0.0004
222 HEPATIC ENZYME ABNORMAL 2 0.0004
223 EXCORIATION 1 0.0004
224 ENDODONTIC PROCEDURE 1 0.0004
225 TOOTH ABSCESS 4 0.0004
226 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
227 PRODUCT COLOUR ISSUE 2 0.0004
228 THYROID DISORDER 6 0.0004
229 DRUG TITRATION ERROR 1 0.0004
230 HAEMORRHAGIC STROKE 3 0.0004
231 TONSILLITIS 2 0.0004
232 RETCHING 8 0.0004
233 MIDDLE INSOMNIA 7 0.0004
234 SINUSITIS 38 0.0004
235 GAMBLING DISORDER 1 0.0004
236 PRODUCT PRESCRIBING ISSUE 8 0.0004
237 GASTRIC PERFORATION 1 0.0004
238 CLUMSINESS 1 0.0004
239 BLOOD PHOSPHORUS INCREASED 1 0.0004
240 JAW DISORDER 2 0.0004
241 MENSTRUAL DISORDER 3 0.0004
242 CHOLECYSTITIS INFECTIVE 1 0.0004
243 TOOTH DISORDER 8 0.0004
244 ENDOTRACHEAL INTUBATION 1 0.0004
245 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
246 PERIORBITAL SWELLING 2 0.0004
247 BREAST CANCER STAGE IV 1 0.0004
248 HAEMATOLOGICAL MALIGNANCY 1 0.0004
249 VITAMIN D DECREASED 3 0.0004
250 PSEUDOMONAS INFECTION 3 0.0003
251 HEART VALVE INCOMPETENCE 1 0.0003
252 BLOOD MAGNESIUM DECREASED 3 0.0003
253 SKIN ATROPHY 2 0.0003
254 HYPOGLYCAEMIC COMA 1 0.0003
255 EYELID MARGIN CRUSTING 1 0.0003
256 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
257 ANOSMIA 5 0.0003
258 DYSPNOEA AT REST 1 0.0003
259 ESCHERICHIA SEPSIS 1 0.0003
260 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
261 URINE ODOUR ABNORMAL 2 0.0003
262 OROPHARYNGEAL DISCOMFORT 3 0.0003
263 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
264 EYE INJURY 1 0.0003
265 DERMATITIS ACNEIFORM 2 0.0003
266 PHARYNGEAL OEDEMA 5 0.0003
267 PIGMENTATION DISORDER 2 0.0003
268 EYELIDS PRURITUS 1 0.0003
269 DRY EYE 16 0.0003
270 INFUSION SITE PRURITUS 1 0.0003
271 SPUTUM DISCOLOURED 3 0.0003
272 THROAT IRRITATION 14 0.0003
273 CHOKING 6 0.0003
274 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
275 POLYP 2 0.0003
276 BREAST ENLARGEMENT 1 0.0003
277 EXPIRED PRODUCT ADMINISTERED 10 0.0003
278 EAR INFECTION 8 0.0003
279 MALIGNANT MELANOMA 4 0.0003
280 COLITIS ISCHAEMIC 2 0.0003
281 SINUS CONGESTION 4 0.0003
282 DRY THROAT 3 0.0003
283 B-CELL LYMPHOMA 1 0.0003
284 SLUGGISHNESS 3 0.0003
285 EYE MOVEMENT DISORDER 2 0.0003
286 PERIPHERAL COLDNESS 4 0.0003
287 PRODUCT DOSE OMISSION 19 0.0003
288 RESPIRATION ABNORMAL 2 0.0003
289 DIVERTICULITIS 8 0.0003
290 APHONIA 4 0.0003
291 CARPAL TUNNEL SYNDROME 4 0.0003
292 HANGOVER 1 0.0003
293 BRONCHITIS 21 0.0003
294 LYMPHOCYTE COUNT DECREASED 5 0.0003
295 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
296 DIVERTICULUM 2 0.0003
297 APPENDICECTOMY 1 0.0003
298 PULMONARY THROMBOSIS 3 0.0003
299 UTERINE LEIOMYOMA 2 0.0003
300 BLINDNESS TRANSIENT 2 0.0003
301 SKIN ULCER 7 0.0003
302 HYPOPHOSPHATAEMIA 2 0.0003
303 SUNBURN 2 0.0003
304 BONE DENSITY ABNORMAL 1 0.0003
305 OCULAR DISCOMFORT 3 0.0003
306 BLOOD CALCIUM DECREASED 3 0.0003
307 CHRONIC SINUSITIS 1 0.0003
308 EYE INFECTION 3 0.0003
309 ASTHMA 30 0.0003
310 LACRIMATION INCREASED 8 0.0003
311 INTERNAL HAEMORRHAGE 3 0.0003
312 SLEEP APNOEA SYNDROME 5 0.0003
313 CLAVICLE FRACTURE 1 0.0003
314 OSTEOARTHRITIS 11 0.0003
315 ELECTROLYTE IMBALANCE 3 0.0003
316 FAECES HARD 1 0.0003
317 PELVIC FRACTURE 2 0.0003
318 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
319 EPISTAXIS 19 0.0003
320 RENAL CYST 2 0.0003
321 GINGIVAL PAIN 2 0.0003
322 CEREBRAL ATROPHY 1 0.0003
323 AZOTAEMIA 1 0.0003
324 CYSTITIS HAEMORRHAGIC 1 0.0002
325 RHINITIS 2 0.0002
326 STENT PLACEMENT 2 0.0002
327 RHINORRHOEA 16 0.0002
328 NOCTURIA 3 0.0002
329 NO THERAPEUTIC RESPONSE 3 0.0002
330 POST PROCEDURAL INFECTION 2 0.0002
331 DECUBITUS ULCER 2 0.0002
332 GOITRE 1 0.0002
333 AORTIC DISSECTION 1 0.0002
334 ACCIDENTAL EXPOSURE 1 0.0002
335 EYE PRURITUS 8 0.0002
336 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
337 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
338 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
339 INTERVERTEBRAL DISC DISORDER 1 0.0002
340 IMPAIRED WORK ABILITY 5 0.0002
341 ALCOHOLISM 1 0.0002
342 ROTATOR CUFF SYNDROME 3 0.0002
343 SOMNOLENCE 47 0.0002
344 PRODUCT CONTAINER ISSUE 2 0.0002
345 IRRITABLE BOWEL SYNDROME 5 0.0002
346 ABNORMAL SENSATION IN EYE 1 0.0002
347 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
348 SKIN SWELLING 2 0.0002
349 PRODUCTIVE COUGH 11 0.0002
350 CHAPPED LIPS 1 0.0002
351 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
352 DIVERTICULUM INTESTINAL 1 0.0002
353 NAIL DISORDER 2 0.0002
354 BLOOD CALCIUM INCREASED 2 0.0002
355 DYSPHEMIA 1 0.0002
356 GINGIVAL SWELLING 1 0.0002
357 SWOLLEN TONGUE 7 0.0002
358 BRAIN NEOPLASM MALIGNANT 1 0.0002
359 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
360 RASH PAPULAR 5 0.0002
361 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
362 DYSPHONIA 13 0.0002
363 NASAL CONGESTION 13 0.0002
364 LEUKOCYTOSIS 4 0.0002
365 LUPUS-LIKE SYNDROME 2 0.0002
366 EXOSTOSIS 2 0.0002
367 HIP FRACTURE 7 0.0002
368 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
369 ORAL DISCOMFORT 3 0.0002
370 INTERCEPTED MEDICATION ERROR 1 0.0002
371 NEPHROPATHY 2 0.0002
372 DIARRHOEA HAEMORRHAGIC 2 0.0002
373 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
374 BLOOD URINE PRESENT 4 0.0002
375 PRODUCT PACKAGING ISSUE 2 0.0002
376 MUSCULOSKELETAL DISORDER 4 0.0002
377 ENDOMETRIOSIS 1 0.0002
378 EYE INFLAMMATION 2 0.0002
379 HUMERUS FRACTURE 1 0.0002
380 ATELECTASIS 2 0.0002
381 INJECTION SITE HAEMATOMA 3 0.0002
382 GUILLAIN-BARRE SYNDROME 1 0.0002
383 FIBROMYALGIA 5 0.0002
384 AUTOIMMUNE DISORDER 2 0.0002
385 VITAMIN D DEFICIENCY 2 0.0002
386 CHEST DISCOMFORT 21 0.0002
387 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
388 HOSPICE CARE 2 0.0002
389 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
390 WHEEZING 12 0.0002
391 INABILITY TO AFFORD MEDICATION 2 0.0002
392 ABDOMINAL TENDERNESS 1 0.0002
393 AGEUSIA 5 0.0002
394 FLUID INTAKE REDUCED 1 0.0002
395 BLOOD POTASSIUM DECREASED 6 0.0002
396 FULL BLOOD COUNT DECREASED 4 0.0002
397 TASTE DISORDER 4 0.0002
398 DYSLIPIDAEMIA 1 0.0002
399 EYELID PTOSIS 2 0.0002
400 TENDONITIS 3 0.0002
401 VENTRICULAR EXTRASYSTOLES 2 0.0002
402 EYE DISCHARGE 2 0.0002
403 PETECHIAE 2 0.0002
404 WEIGHT FLUCTUATION 2 0.0002
405 FOOD CRAVING 1 0.0002
406 MOUTH ULCERATION 4 0.0002
407 INCONTINENCE 2 0.0002
408 RESPIRATORY TRACT CONGESTION 3 0.0002
409 HEPATIC FUNCTION ABNORMAL 7 0.0002
410 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
411 COMPRESSION FRACTURE 1 0.0002
412 HEREDITARY ANGIOEDEMA 2 0.0002
413 INTESTINAL RESECTION 1 0.0002
414 DECREASED ACTIVITY 2 0.0002
415 PHARYNGITIS STREPTOCOCCAL 2 0.0002
416 ASPIRATION 2 0.0002
417 EYE DISORDER 6 0.0002
418 MELAENA 4 0.0002
419 PHOTOSENSITIVITY REACTION 3 0.0002
420 TOOTH FRACTURE 2 0.0002
421 STOMATITIS 11 0.0002
422 CHOKING SENSATION 1 0.0002
423 DENTAL CARIES 2 0.0002
424 CYSTIC FIBROSIS 1 0.0002
425 GASTRIC ULCER HAEMORRHAGE 1 0.0002
426 VENTRICULAR FIBRILLATION 2 0.0002
427 FUNGAL INFECTION 6 0.0002
428 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
429 HEART RATE ABNORMAL 1 0.0002
430 HAEMOPTYSIS 5 0.0002
431 ANGIOPATHY 1 0.0002
432 COUGH 50 0.0002
433 CANDIDA INFECTION 3 0.0002
434 HEMIPARESIS 3 0.0002
435 IMPAIRED DRIVING ABILITY 2 0.0002
436 SCAR 3 0.0002
437 MICTURITION URGENCY 2 0.0002
438 CARDIAC VALVE DISEASE 1 0.0002
439 HERPES VIRUS INFECTION 1 0.0002
440 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
441 MUSCULOSKELETAL PAIN 9 0.0002
442 RASH MACULAR 6 0.0002
443 HYPOVOLAEMIA 1 0.0002
444 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
445 SEXUAL DYSFUNCTION 2 0.0002
446 COVID-19 PNEUMONIA 2 0.0002
447 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
448 OCULAR HYPERAEMIA 8 0.0002
449 ATAXIA 2 0.0002
450 NEUROPATHY PERIPHERAL 16 0.0002
451 CATARACT 10 0.0002
452 GOUT 3 0.0002
453 WRIST FRACTURE 2 0.0002
454 HEARING IMPAIRED 1 0.0002
455 BLOOD PRESSURE FLUCTUATION 4 0.0002
456 BLOOD GLUCOSE DECREASED 8 0.0002
457 IRRITABILITY 10 0.0002
458 GASTROENTERITIS VIRAL 3 0.0002
459 RESTLESS LEGS SYNDROME 3 0.0002
460 C-REACTIVE PROTEIN INCREASED 6 0.0002
461 ADRENAL INSUFFICIENCY 2 0.0002
462 NEURALGIA 4 0.0002
463 CONJUNCTIVITIS 3 0.0002
464 CYST 2 0.0002
465 INFUSION SITE EXTRAVASATION 1 0.0002
466 PNEUMONIA 52 0.0002
467 CONSTIPATION 35 0.0002
468 VISION BLURRED 22 0.0002
469 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
470 BLOOD SODIUM DECREASED 3 0.0002
471 INFUSION SITE SWELLING 1 0.0002
472 CYSTITIS 5 0.0002
473 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
474 PRODUCT SUBSTITUTION ISSUE 9 0.0002
475 ACUTE RESPIRATORY FAILURE 3 0.0002
476 GALACTORRHOEA 1 0.0002
477 INCOHERENT 1 0.0002
478 RASH GENERALISED 4 0.0002
479 HIATUS HERNIA 2 0.0002
480 EAR PAIN 3 0.0002
481 HERPES SIMPLEX 1 0.0002
482 HAEMORRHOIDS 3 0.0002
483 ORAL HERPES 3 0.0002
484 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
485 ARTHRITIS 12 0.0002
486 ASPERGILLUS INFECTION 1 0.0002
487 HYPOGAMMAGLOBULINAEMIA 1 0.0002
488 ORAL CANDIDIASIS 2 0.0002
489 TOOTH INFECTION 2 0.0002
490 PULMONARY CONGESTION 2 0.0002
491 OROPHARYNGEAL PAIN 14 0.0002
492 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
493 APPETITE DISORDER 1 0.0002
494 COGNITIVE DISORDER 7 0.0001
495 SPINAL FRACTURE 3 0.0001
496 FEAR 4 0.0001
497 THROAT TIGHTNESS 4 0.0001
498 PRODUCT TASTE ABNORMAL 2 0.0001
499 OEDEMA PERIPHERAL 18 0.0001
500 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
501 BODY TEMPERATURE INCREASED 3 0.0001
502 FEELING HOT 9 0.0001
503 ABNORMAL LOSS OF WEIGHT 1 0.0001
504 MOOD ALTERED 4 0.0001
505 ECCHYMOSIS 1 0.0001
506 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
507 GASTRIC DISORDER 5 0.0001
508 HAEMATOCHEZIA 8 0.0001
509 DROOLING 1 0.0001
510 FORMICATION 1 0.0001
511 ROAD TRAFFIC ACCIDENT 6 0.0001
512 EXTRASYSTOLES 1 0.0001
513 DERMATITIS 3 0.0001
514 DEMENTIA 4 0.0001
515 PERIPHERAL SWELLING 22 0.0001
516 KNEE ARTHROPLASTY 3 0.0001
517 HEART RATE DECREASED 5 0.0001
518 APPLICATION SITE REACTION 1 0.0001
519 DUODENAL ULCER 1 0.0001
520 MYALGIA 24 0.0001
521 FEAR OF INJECTION 1 0.0001
522 LIVER FUNCTION TEST INCREASED 3 0.0001
523 HERPES ZOSTER 8 0.0001
524 IMPAIRED QUALITY OF LIFE 2 0.0001
525 PRURITUS GENERALISED 3 0.0001
526 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
527 MYELODYSPLASTIC SYNDROME 2 0.0001
528 DERMATITIS BULLOUS 1 0.0001
529 HYPERTHYROIDISM 2 0.0001
530 FLUID RETENTION 7 0.0001
531 PANIC ATTACK 5 0.0001
532 CHILLS 16 0.0001
533 SURGERY 8 0.0001
534 APPLICATION SITE PAIN 3 0.0001
535 LABORATORY TEST ABNORMAL 4 0.0001
536 ARTHROPOD BITE 1 0.0001
537 DYSGEUSIA 10 0.0001
538 EYE SWELLING 5 0.0001
539 GLOSSODYNIA 3 0.0001
540 ORAL PAIN 3 0.0001
541 HYDRONEPHROSIS 1 0.0001
542 BREAST TENDERNESS 1 0.0001
543 DYSPNOEA EXERTIONAL 5 0.0001
544 DYSPEPSIA 13 0.0001
545 ECONOMIC PROBLEM 2 0.0001
546 TINNITUS 6 0.0001
547 SKIN DISCOLOURATION 6 0.0001
548 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
549 HEADACHE 81 0.0001
550 CONCUSSION 1 0.0001
551 FEMUR FRACTURE 4 0.0001
552 APHTHOUS ULCER 1 0.0001
553 BLOOD CHOLESTEROL INCREASED 6 0.0001
554 APNOEA 1 0.0001
555 FATIGUE 100 0.0001
556 BASAL CELL CARCINOMA 2 0.0001
557 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
558 PARAESTHESIA 20 0.0001
559 FURUNCLE 1 0.0001
560 BLOOD ALBUMIN DECREASED 1 0.0001
561 MIGRAINE 12 0.0001
562 INJECTION SITE BRUISING 10 0.0001
563 ATRIAL FLUTTER 1 0.0001
564 NECK PAIN 7 0.0001
565 BLOOD DISORDER 1 0.0001
566 BLISTER 7 0.0001
567 SENSORY DISTURBANCE 2 0.0001
568 MENTAL IMPAIRMENT 3 0.0001
569 EXTRA DOSE ADMINISTERED 5 0.0001
570 BACK DISORDER 2 0.0001
571 ASPHYXIA 1 0.0001
572 ASTHENIA 46 0.0001
573 ABNORMAL FAECES 1 0.0001
574 PLATELET COUNT DECREASED 13 0.0001
575 HICCUPS 1 0.0001
576 HYPERAESTHESIA 1 0.0001
577 EYE IRRITATION 7 0.0001
578 MANIA 2 0.0001
579 VENTRICULAR TACHYCARDIA 2 0.0001
580 TREMOR 20 0.0001
581 DIZZINESS 60 0.0001
582 VIRAL INFECTION 4 0.0001
583 LIP SWELLING 4 0.0001
584 COAGULOPATHY 2 0.0001
585 SKIN DISORDER 4 0.0001
586 HAEMODIALYSIS 1 0.0001
587 FACE OEDEMA 2 0.0001
588 CHRONIC KIDNEY DISEASE 9 0.0001
589 DISEASE PROGRESSION 14 0.0001
590 FACIAL PARALYSIS 1 0.0001
591 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
592 INFLUENZA 13 0.0001
593 RECTAL HAEMORRHAGE 5 0.0001
594 HYPOACUSIS 5 0.0001
595 PARANOIA 2 0.0001
596 DYSPHAGIA 11 0.0001
597 CARDIAC MURMUR 1 0.0001
598 JOINT STIFFNESS 3 0.0001
599 GASTRITIS 3 0.0001
600 GROIN PAIN 1 0.0001
601 COLD SWEAT 2 0.0001
602 DIARRHOEA 73 0.0001
603 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
604 DRUG ERUPTION 2 0.0001
605 PYREXIA 39 0.0001
606 FACIAL PAIN 1 0.0001
607 PAIN IN EXTREMITY 33 0.0001
608 FREQUENT BOWEL MOVEMENTS 3 0.0001
609 PALPITATIONS 13 0.0001
610 RASH PRURITIC 6 0.0001
611 LIMB INJURY 3 0.0001
612 CRYING 4 0.0001
613 DEPRESSION 25 0.0001
614 BONE DISORDER 2 0.0001
615 MUSCLE SPASMS 20 0.0001
616 BRAIN NEOPLASM 1 0.0001
617 RESPIRATORY ARREST 3 0.0001
618 INJECTION SITE MASS 4 0.0001
619 PROCEDURAL PAIN 3 0.0001
620 MENTAL STATUS CHANGES 3 0.0001
621 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
622 ABDOMINAL PAIN 25 0.0001
623 HEPATIC STEATOSIS 2 0.0001
624 THINKING ABNORMAL 2 0.0001
625 BACTERIAL INFECTION 2 0.0001
626 MALAISE 47 0.0001
627 HEPATIC ENCEPHALOPATHY 1 0.0001
628 APPENDICITIS 1 0.0001
629 CARDIAC DISORDER 10 0.0001
630 ABDOMINAL PAIN UPPER 22 0.0001
631 ILLNESS 11 0.0001
632 PRURITUS 41 0.0001
633 ARTERIOSCLEROSIS 1 0.0001
634 HOT FLUSH 8 0.0001
635 INTESTINAL OBSTRUCTION 4 0.0001
636 UNEVALUABLE EVENT 8 0.0001
637 ARRHYTHMIA 5 0.0001
638 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
639 RED BLOOD CELL COUNT DECREASED 3 0.0001
640 BLOOD PRESSURE INCREASED 16 0.0001
641 HYPERSOMNIA 3 0.0001
642 VOMITING 49 0.0001
643 CHOLESTASIS 2 0.0001
644 SEROTONIN SYNDROME 2 0.0001
645 CONTUSION 10 0.0001
646 GLAUCOMA 2 0.0001
647 INFECTION 15 0.0001
648 HERNIA 2 0.0001
649 BACK PAIN 24 0.0001
650 INTERSTITIAL LUNG DISEASE 5 0.0001
651 DIZZINESS POSTURAL 1 0.0001
652 NASOPHARYNGITIS 19 0.0001
653 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
654 SKIN FISSURES 2 0.0001
655 ERYTHEMA 21 0.0001
656 HEPATOMEGALY 1 0.0001
657 INSOMNIA 27 0.0001
658 HAEMATOCRIT DECREASED 2 0.0001
659 PRESCRIBED UNDERDOSE 2 0.0001
660 HYPOAESTHESIA 15 0.0001
661 THROMBOSIS 8 0.0001
662 CELLULITIS 5 0.0001
663 PRODUCT PHYSICAL ISSUE 2 0.0001
664 EMPHYSEMA 1 0.0001
665 PRODUCT ADMINISTRATION ERROR 2 0.0001
666 FEEDING DISORDER 2 0.0001
667 VERTIGO 6 0.0001
668 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
669 FLUSHING 10 0.0001
670 EPILEPSY 3 0.0001
671 INITIAL INSOMNIA 1 0.0001
672 EAR DISCOMFORT 1 0.0001
673 HELICOBACTER INFECTION 1 0.0001
674 INFLAMMATION 5 0.0001
675 SWELLING 9 0.0001
676 CARDIO-RESPIRATORY ARREST 4 0.0001
677 DYSPNOEA 54 0.0001
678 INJECTION SITE DISCOMFORT 1 0.0001
679 ANXIETY 27 0.0001
680 HEAD INJURY 3 0.0001
681 RENAL FAILURE ACUTE 4 0.0001
682 RASH 41 0.0001
683 EATING DISORDER 2 0.0001
684 NAUSEA 74 0.0001
685 BREAST CANCER METASTATIC 1 0.0001
686 POOR QUALITY SLEEP 2 0.0001
687 DRUG EFFECT DECREASED 5 0.0001
688 BIPOLAR DISORDER 1 0.0001
689 BACK INJURY 1 0.0001
690 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
691 INTENTIONAL PRODUCT MISUSE 8 0.0001
692 HEART RATE INCREASED 9 0.0001
693 ANGIOEDEMA 4 0.0001
694 DECREASED APPETITE 21 0.0001
695 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
696 FOOT DEFORMITY 1 0.0001
697 LIVER DISORDER 4 0.0001
698 STEVENS-JOHNSON SYNDROME 2 0.0001
699 ARTHROPATHY 5 0.0001
700 TRANSAMINASES INCREASED 2 0.0001
701 ABDOMINAL DISCOMFORT 15 0.0001
702 ARTHRALGIA 37 0.0001
703 OXYGEN SATURATION DECREASED 5 0.0001
704 EYE PAIN 5 0.0001
705 MUSCULAR WEAKNESS 10 0.0001
706 PRODUCT AVAILABILITY ISSUE 2 0.0001
707 MEMORY IMPAIRMENT 12 0.0001
708 SHOCK 2 0.0001
709 MUSCLE TWITCHING 2 0.0001
710 NIGHTMARE 3 0.0001
711 DRY MOUTH 7 0.0001
712 HYPERSENSITIVITY 16 0.0001
713 EYELID OEDEMA 1 0.0001
714 WEIGHT DECREASED 24 0.0001
715 RENAL DISORDER 4 0.0001
716 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
717 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
718 BURNING SENSATION 6 0.0001
719 BONE PAIN 5 0.0001
720 SLEEP DISORDER 6 0.0001
721 LYMPHADENOPATHY 3 0.0001
722 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
723 BLOOD IRON DECREASED 1 0.0001
724 BACTERAEMIA 1 0.0001
725 FALL 28 0.0001
726 CHOLECYSTITIS 1 0.0001
727 URTICARIA 14 0.0001
728 JOINT SWELLING 10 0.0001
729 LOCALISED INFECTION 2 0.0001
730 DRUG EFFECT INCOMPLETE 3 0.0001
731 DRY SKIN 11 0.0001
732 PLEURAL EFFUSION 5 0.0001
733 ATRIAL FIBRILLATION 8 0.0001
734 DISCOMFORT 5 0.0001
735 CEREBRAL INFARCTION 2 0.0001
736 LUNG DISORDER 4 0.0001
737 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
738 PAIN 50 0.0001
739 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
740 CARDIOMEGALY 1 0.0001
741 ABASIA 2 0.0001
742 GENERALISED OEDEMA 1 0.0001
743 CONFUSIONAL STATE 13 0.0001
744 APPLICATION SITE IRRITATION 1 0.0001
745 INJECTION SITE DISCOLOURATION 1 0.0001
746 PRODUCT USE ISSUE 15 0.0001
747 FEELING ABNORMAL 19 0.0001
748 BRAIN OEDEMA 1 0.0001
749 ACNE 6 0.0001
750 ABDOMINAL PAIN LOWER 2 0.0001
751 PRODUCT COMPLAINT 2 0.0001
752 DRUG INEFFECTIVE 104 0.0001
753 GAIT DISTURBANCE 15 0.0001
754 ERECTILE DYSFUNCTION 2 0.0001
755 ANAPHYLACTIC SHOCK 2 0.0001
756 INJECTION SITE INDURATION 1 0.0001
757 DEEP VEIN THROMBOSIS 5 0.0001
758 PLASMA CELL MYELOMA 3 0.0001
759 AMNESIA 5 0.0001
760 RESPIRATORY TRACT INFECTION 2 0.0001
761 DEAFNESS 2 0.0001
762 SUICIDAL IDEATION 7 0.0001
763 ECZEMA 4 0.0001
764 SPEECH DISORDER 4 0.0001
765 APPLICATION SITE ERYTHEMA 2 0.0001
766 URINARY TRACT INFECTION 13 0.0001
767 BEDRIDDEN 1 0.0001
768 IMMUNE SYSTEM DISORDER 1 0.0001
769 DERMATITIS ATOPIC 4 0.0001
770 RENAL FAILURE 10 0.0001
771 BLOOD PRESSURE DECREASED 5 0.0001
772 DEHYDRATION 10 0.0001
773 EYE HAEMORRHAGE 1 0.0001
774 CARDIAC FAILURE CONGESTIVE 6 0.0001
775 JAUNDICE 2 0.0001
776 PAIN OF SKIN 2 0.0001
777 OEDEMA 4 0.0001
778 GINGIVAL BLEEDING 1 0.0001
779 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
780 OSTEOPOROSIS 3 0.0001
781 SKIN LESION 2 0.0001
782 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
783 CARDIAC ARREST 6 0.0001
784 RESPIRATORY DISTRESS 2 0.0001
785 ABNORMAL DREAMS 2 0.0001
786 ANAPHYLACTIC REACTION 4 0.0001
787 COORDINATION ABNORMAL 1 0.0001
788 BLINDNESS UNILATERAL 1 0.0001
789 HYPERTENSION 15 0.0001
790 RHEUMATOID ARTHRITIS 8 0.0001
791 LOSS OF CONSCIOUSNESS 9 0.0001
792 CONVULSION 4 0.0001
793 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
794 SEIZURE 8 0.0001
795 DEVICE LEAKAGE 3 0.0001
796 CONDITION AGGRAVATED 21 0.0001
797 SEPTIC SHOCK 3 0.0001
798 HYPOKINESIA 1 0.0001
799 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
800 FLUID OVERLOAD 1 0.0001
801 NEEDLE ISSUE 2 0.0001
802 APATHY 1 0.0001
803 AGITATION 5 0.0001
804 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
805 CARDIOMYOPATHY 1 0.0001
806 IMMUNODEFICIENCY 1 0.0001
807 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
808 GASTROINTESTINAL DISORDER 6 0.0001
809 HAEMORRHAGE 7 0.0001
810 RESPIRATORY DISORDER 2 0.0001
811 THERAPY NON-RESPONDER 3 0.0001
812 BONE LOSS 1 0.0001
813 HALLUCINATION 5 0.0001
814 APHASIA 2 0.0001
815 CORONARY ARTERY DISEASE 2 0.0001
816 ILL-DEFINED DISORDER 4 0.0001
817 INSURANCE ISSUE 1 0.0001
818 CHEST PAIN 12 0.0001
819 DELUSION 1 0.0001
820 ACUTE MYELOID LEUKAEMIA 1 0.0001
821 BRAIN FOG 1 0.0001
822 CYANOSIS 1 0.0001
823 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
824 HALLUCINATION, AUDITORY 1 0.0001
825 RASH ERYTHEMATOUS 3 0.0001
826 MULTIPLE SCLEROSIS 3 0.0001
827 ABSCESS 1 0.0001
828 THROMBOCYTOPENIA 7 0.0001
829 WEIGHT INCREASED 14 0.0001
830 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
831 NIGHT SWEATS 2 0.0001
832 BLOOD POTASSIUM INCREASED 1 0.0001
833 SWELLING FACE 4 0.0001
834 BLOOD CREATININE INCREASED 4 0.0001
835 PRODUCT DOSE OMISSION ISSUE 18 0.0001
836 IMPAIRED HEALING 2 0.0001
837 INFLUENZA LIKE ILLNESS 5 0.0001
838 STAPHYLOCOCCAL INFECTION 2 0.0001
839 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
840 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
841 DRUG LEVEL INCREASED 1 0.0001
842 FEBRILE NEUTROPENIA 4 0.0001
843 URINARY RETENTION 2 0.0001
844 GAIT INABILITY 2 0.0001
845 HYPOTENSION 12 0.0001
846 BLOOD UREA INCREASED 1 0.0001
847 INJECTION SITE PRURITUS 4 0.0001
848 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
849 CEREBROVASCULAR ACCIDENT 10 0.0001
850 THERAPY CESSATION 3 0.0001
851 INJECTION SITE REACTION 4 0.0001
852 BALANCE DISORDER 5 0.0001
853 DEVICE DEFECTIVE 1 0.0001
854 ANAEMIA 11 0.0001
855 NEOPLASM PROGRESSION 2 0.0001
856 ABDOMINAL DISTENSION 6 0.0001
857 NERVOUSNESS 3 0.0001
858 DEVICE USE ISSUE 1 0.0001
859 MUSCULOSKELETAL STIFFNESS 5 0.0001
860 HYPERKALAEMIA 2 0.0001
861 HYPOXIA 2 0.0001
862 DEPRESSED MOOD 3 0.0001
863 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
864 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
865 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
866 GALLBLADDER DISORDER 1 0.0001
867 PRODUCT ADHESION ISSUE 2 0.0001
868 THERAPY INTERRUPTED 4 0.0001
869 CEREBRAL HAEMORRHAGE 2 0.0001
870 MOBILITY DECREASED 4 0.0001
871 ADVERSE DRUG REACTION 5 0.0001
872 DISTURBANCE IN ATTENTION 3 0.0001
873 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
874 TREATMENT NONCOMPLIANCE 3 0.0001
875 END STAGE RENAL DISEASE 1 0.0001
876 DYSURIA 2 0.0001
877 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
878 BLOOD GLUCOSE ABNORMAL 1 0.0001
879 SEPSIS 6 0.0001
880 PANCYTOPENIA 3 0.0001
881 HYPONATRAEMIA 3 0.0001
882 HEPATIC CIRRHOSIS 1 0.0001
883 HYPOCALCAEMIA 1 0.0001
884 FOOT FRACTURE 1 0.0001
885 DIABETES MELLITUS 4 0.0001
886 INCREASED APPETITE 1 0.0001
887 ALOPECIA 10 0.0001
888 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
889 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
890 ABNORMAL BEHAVIOUR 2 0.0001
891 DRUG INTERACTION 8 0.0001
892 BLOOD PRESSURE ABNORMAL 1 0.0001
893 INJECTION SITE HAEMORRHAGE 4 0.0001
894 THERAPEUTIC RESPONSE DECREASED 3 0.0000
895 HAEMOGLOBIN DECREASED 5 0.0000
896 VISUAL IMPAIRMENT 6 0.0000
897 INJECTION SITE ERYTHEMA 6 0.0000
898 POLLAKIURIA 2 0.0000
899 INTENTIONAL DRUG MISUSE 1 0.0000
900 RENAL IMPAIRMENT 4 0.0000
901 SKIN EXFOLIATION 4 0.0000
902 HYPERHIDROSIS 6 0.0000
903 FAECES DISCOLOURED 1 0.0000
904 VAGINAL HAEMORRHAGE 2 0.0000
905 TACHYCARDIA 4 0.0000
906 CHROMATURIA 1 0.0000
907 HEART RATE IRREGULAR 1 0.0000
908 APPLICATION SITE PRURITUS 1 0.0000
909 INCORRECT DOSE ADMINISTERED 10 0.0000
910 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
911 ADVERSE EVENT 4 0.0000
912 BREAST CANCER 4 0.0000
913 INJECTION SITE PAIN 13 0.0000
914 PULMONARY EMBOLISM 4 0.0000
915 RENAL CANCER 2 0.0000
916 DRUG INTOLERANCE 4 0.0000
917 HYPOGLYCAEMIA 2 0.0000
918 UNDERDOSE 3 0.0000
919 INJECTION SITE URTICARIA 1 0.0000
920 ENCEPHALOPATHY 1 0.0000
921 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
922 MYOCARDIAL INFARCTION 7 0.0000
923 SYNCOPE 4 0.0000
924 AGGRESSION 2 0.0000
925 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
926 CARDIOVASCULAR DISORDER 1 0.0000
927 HYPOPHAGIA 1 0.0000
928 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
929 HOSPITALISATION 6 0.0000
930 DRUG RESISTANCE 1 0.0000
931 DIPLOPIA 1 0.0000
932 ANHEDONIA 1 0.0000
933 PANCREATITIS 2 0.0000
934 BRADYCARDIA 2 0.0000
935 BREAST CANCER FEMALE 1 0.0000
936 CARDIAC FAILURE 3 0.0000
937 BLOOD GLUCOSE INCREASED 7 0.0000
938 DEATH 32 0.0000
939 BLOOD BILIRUBIN INCREASED 1 0.0000
940 DRUG DOSE OMISSION 6 0.0000
941 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
942 FLATULENCE 2 0.0000
943 LETHARGY 2 0.0000
944 DYSSTASIA 1 0.0000
945 ASCITES 1 0.0000
946 HEPATIC FAILURE 1 0.0000
947 SUICIDE ATTEMPT 2 0.0000
948 ACUTE KIDNEY INJURY 5 0.0000
949 INJECTION SITE RASH 1 0.0000
950 DRUG ADMINISTRATION ERROR 1 0.0000
951 EMOTIONAL DISORDER 1 0.0000
952 EXPOSURE DURING PREGNANCY 2 0.0000
953 BONE DENSITY DECREASED 1 0.0000
954 DRUG-INDUCED LIVER INJURY 1 0.0000
955 HYPOTHYROIDISM 1 0.0000
956 CHOLELITHIASIS 1 0.0000
957 NEOPLASM MALIGNANT 2 0.0000
958 ANGER 1 0.0000
959 PRODUCT QUALITY ISSUE 4 0.0000
960 NEUTROPENIA 4 0.0000
961 HEPATIC ENZYME INCREASED 2 0.0000
962 HAEMATURIA 1 0.0000
963 COVID-19 5 0.0000
964 INJURY 2 0.0000
965 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
966 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
967 HYPERGLYCAEMIA 1 0.0000
968 RESPIRATORY FAILURE 2 0.0000
969 OFF LABEL USE 24 0.0000
970 INJECTION SITE SWELLING 2 0.0000
971 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
972 DISORIENTATION 1 0.0000
973 EMOTIONAL DISTRESS 3 0.0000
974 DYSKINESIA 1 0.0000
975 BLINDNESS 1 0.0000
976 TOXICITY TO VARIOUS AGENTS 4 0.0000
977 PRODUCT STORAGE ERROR 2 0.0000
978 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
979 DRUG WITHDRAWAL SYNDROME 2 0.0000
980 DEVICE ISSUE 2 0.0000
981 NO ADVERSE EVENT 4 0.0000
982 HYPOKALAEMIA 1 0.0000
983 COMA 1 0.0000
984 DRUG DEPENDENCE 3 0.0000
985 OVERDOSE 4 0.0000
986 DEPENDENCE 1 0.0000
987 INFUSION RELATED REACTION 1 0.0000
988 DEVICE MALFUNCTION 1 0.0000
989 DRUG ABUSE 1 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000